Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Gibson

Plastic and Reconstructive Surgery Miami, FL Medical Doctor

NPI 1689650079 CMS profile 121013

3661 S Miami Ave, Ste 403, Miami, FL 33133

Open in the dashboard

General payments

$34,081

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Gibson of Miami, FL is reported in the CMS Open Payments database as having received $34,081 across 121 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,190 18
2024 General $2,969 14
2023 General $7,197 21
2022 General $9,202 28
2021 General $1,316 14
2020 General $2,777 17
2019 General $3,430 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Gibson
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Jeffrey Gibson were reported at $7,190. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Jeffrey Gibson Plastic and Reconstructive Surgery median Middle half National median
2019 $3,430 $335 $121–$1,264 $163
2020 $2,777 $162 $57–$417 $114
2021 $1,316 $245 $89–$735 $132
2022 $9,202 $325 $120–$932 $149
2023 $7,197 $343 $129–$999 $160
2024 $2,969 $390 $141–$1,085 $164
2025 $7,190 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TissueTech, Inc. $22,388 29 payments
  2. Amniox Medical, Inc. $5,487 7 payments
  3. TELA Bio, Inc. $4,114 32 payments
  4. Integra LifeSciences Corporation $345 4 payments
  5. Sanara MedTech Inc. $241 2 payments
  6. Smith+Nephew, Inc. $240 5 payments
  7. Avita Medical Americas, LLC $163 2 payments
  8. Allergan Inc. $139 6 payments
  9. Endo Pharmaceuticals Inc. $139 7 payments
  10. KCI USA, Inc $129 2 payments
  11. Other $697 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $12,015 4 payments
  2. Travel and Lodging $11,664 13 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $4,800 2 payments
  4. Food and Beverage $4,543 100 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $900 1 payment
  6. Long term medical supply or device loan $159 1 payment
Products named General payments · program years 2019–2025
  1. CLARIX Human Tissue Products $10,818 11 payments
  2. NEOX Human Tissue Products $5,487 7 payments
  3. CLARIX Human Tissue Products $5,487 7 payments
  4. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $4,031 26 payments
  5. NEOX Human Tissue Products $1,130 5 payments
  6. CellerateRx $241 2 payments
  7. ACell $159 1 payment
  8. XIAFLEX $139 7 payments
  9. Recell $132 1 payment
  10. PICO Single Use Negative Pressure Wound Therapy $130 2 payments
  11. Other $2,947 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

387

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$649

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

57.1%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Acetaminophen-Codeine Acetaminophen With Codeine Brand 161 $328
Cephalexin Generic 151 $200
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 60 $80
Ciprofloxacin Hcl Generic 15 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$47,525

Medicare's payments for the services billed

Medicare patients

27

Average age 74

Services billed

139

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 59%
Arthritis 44%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record